Hillmen, Peter, Italy

• Hematology Meeting Reports (formerly Haematologica Reports) Vol. 1 No. 2: Is Elimination of Minimal Residual Disease Significant for the Outcome of CLL? The Role of Alemtuzumab - Articles
  The role of alemtuzumab in the treatment of chronic lymphocytic leukemia (CLL) and the achievement of minimal residual disease negativity in relapsed/refractory CLL
  Abstract  PDF
• Hematology Meeting Reports (formerly Haematologica Reports) Vol. 1 No. 5: Changing the paradigm: new perspectives in the treatment of haematological malignancies - Articles
  Fludarabine plus cyclophosphamide combination: a new standard for first-line therapy in chronic lymphocytic leukaemiaa
  Abstract  PDF